SPEAKERS - May 25th
Ana Konvalinka, MD, PhD, FRCPC
Transplant Nephrologist,
Clinician Scientist
Department of Medicine, Division of Nephrology, University Health Network
Director,
Multi-organ Transplant Biobank, Ajmera Transplant Centre
Senior Scientist, Toronto General Hospital
Research Institute
Assistant Professor, University of Toronto
Dr. Ana Konvalinka (MD, PhD, FRCPC) is a clinician scientist and transplant nephrologist at the University Health Network in Toronto. She is an Assistant Professor at the University of Toronto and a Senior Scientist at Toronto General Hospital Research Institute. Following a bachelor’s degree in Human Biology at the University of Toronto, Dr. Konvalinka completed medical studies at the University of Ottawa in 2003. She then completed internal medicine and nephrology training in Toronto in 2008. She subsequently embarked on a PhD in basic science, under the supervision of Dr. James Scholey and Dr. Eleftherios Diamandis. Her PhD thesis addressed the effect of angiotensin II on the proteome of primary human proximal tubular cells, and the relevance of this effect in vivo. Following completion of her PhD in 2013, she went on to do the clinical kidney transplant fellowship at Toronto General Hospital. Dr. Konvalinka joined faculty at the University Health Network in 2015. Her main clinical and research interests are in antibody-mediated rejection and kidney allograft fibrosis. She utilizes systems biology approaches and proteomics to enhance the understanding of the mechanisms, derive novel markers and identify therapeutic targets for kidney disease. Dr. Konvalinka is the director of the Multi-Organ Transplant biobank for kidney, pancreas, and liver transplant programs at the Ajmera Transplant Centre. She has received international research awards (the Human Proteome Project (2016), the American Society of Transplantation Faculty-Development Research Grant (2016) and the Advances in Organ Transplantation Award (2015)) and national research awards (Canadian Society of Transplantation Research Excellence Award (2020), Canadian Society of Nephrology New Investigator Lectureship (2017) and the KRESCENT New Investigator Award (2016)).
Adriana Valverde, MD
Clinical Associate, Lung Transplant
Program, Ajmera Center
Pulmonologist and Clinical Associate in the Lung Transplant Program in Toronto. Trained in Costa Rica, and Co-director of the Lung Transplant Program in her home center.
Asma Syed, MBBS, MD, FRCPC
Assistant Professor, University
of Toronto
Consultant in Transplant Infectious Diseases, Ajmera Transplant Centre
Dr. Asma Syed is an Assistant Professor at the University of Toronto and Clinician-Teacher in the Transplant Infectious Diseases Program in the Ajmera Transplant Centre. She trained in Transplant ID at Western University in London, Ontario.
She has over five years of clinical experience as faculty in Infectious Diseases and has primarily practiced in the United States before moving to Canada in 2020[check date]. Her interests include Clinical teaching in Immunocompromised Host Infectious Diseases and Education in Wellness, Equity and Diversity. She also participates on the Infectious Diseases Education workgroup of the American Society of Transplantation.
Cecilia Chaparro, MD, MSc
Associate Professor of Medicine, University of Toronto
Respirologist, Toronto Lung Transplant Program
Fellowship Program Director Respirology, University of Toronto
Staff Respirologist, Toronto General Hospital, Adult Cystic Fibrosis Program St. Michael’s Hospital
Born and trained as respirologist in Bogota, Colombia. Part of the Toronto Lung Transplant Program since 1992; Dr. Chaparro was the first cross appointment as a Respirologist at The University Health Network, Toronto Lung Transplant Program, at the Toronto General Hospital and the Adult Cystic Fibrosis Program, MAIN CLINICAL AND RESEARCH INTEREST. Outcomes of CF patients post lung transplantation: Infections, non-lung complications: gastrointestinal, cystic fibrosis related diabetes and women’s health. Quality Improvement work on transition to transplant from cystic fibrosis care. Several initiatives with CF Canada and North American Cystic Fibrosis Foundation.
Coleman Rotstein, MD, FRCPC, FACP, FIDSA, FAMMI
Dr. Rotstein is Professor of Medicine in the Division of Infectious Diseases at the University of Toronto and Attending Physician at the University Health Network, Toronto, Ontario. He received a Bachelor of Science at the University of Toronto and earned his medical degree from the University of Calgary in 1976. Dr. Rotstein completed his specialty training in Internal Medicine at the University of Toronto and pursued further subspecialty training in Infectious Diseases & Immunology at the Medical University of South Carolina in Charleston, South Carolina from 1980 to 1983 [ABIM (1980), FRCPC (Internal Medicine 1981), Infectious Diseases ABIM (1982)].
Dr. Rotstein is currently the Director of Oncologic Infectious Diseases of the Immunocompromised Host Infectious Diseases Service at the University Health Network. He was a member of the Board of the Canadian Foundation for Infectious Diseases until 2021 and the Past Chair of the Awards Committee of the Foundation. Dr. Rotstein was also a member of the National Advisory Committee on Immunization of the Public Health Agency of Canada from 2017-2021. In addition, he has been elected a fellow of the American College of Physicians and the Infectious Diseases Society of America. He is also a fellow of the European Confederation of Medical Mycology. He functions as a reviewer for several international journals.
Dr. Rotstein has published over 195 peer-reviewed papers. His research interests have focused mainly on infections in cancer patients and other immunocompromised hosts.
Chaya Shwaartz MD
Assistant professor, Department of General
Surgery, University of Toronto
Abdominal Transplant & HPB Surgical Oncology
Dr. Chaya Shwaartz is an assistant Professor in the Division of General Surgery at UHN and the Department of Surgery. She completed her fellowship in Abdominal Transplant and HPB surgical oncology was done at U of T, Toronto General Hospital.
Dr. Shwaartz main interests are minimally invasive surgery and surgical education. She is codirector of the Abdominal Transplant and Hepatobiliary Surgery fellowship at the University of Toronto.
Cynthia Tsien
Education Director, Ajmera Transplant Centre –
University Health Network
Assistant Professor of Medicine
Dr. Cynthia Tsien, MDCM, MPH, FRCPC, is the Education Director at the Soham & Shaila Ajmera Family Transplant Centre. She completed her residency in Internal Medicine and Gastroenterology at McGill University. She underwent training in hepatology, transplant hepatology, and research at the Toronto General Hospital and Cleveland Clinic. She obtained a Master in Public Health at the John Hopkins University. She specializes in the care of patients with liver disease pre- and post-transplant. Her research interests include sarcopenia, portal hypertension, and education.
Dr. Darshan H. Brahmbhatt, MB BChir MD(Res)
Heart Failure
Fellow, Mount Sinai and Toronto General Hospitals, University of Toronto.
Darshan Brahmbhatt is a cardiologist who joined the HF/Transplant team in Toronto as a clinical fellow from London, UK in October 2019. He completed his clinical training in Cardiology, sub-specialising in heart failure/cardiac transplant and complex device implantation at Royal Papworth Hospital, subsequently completing his Doctoral research at the Royal Brompton Hospital & Imperial College London on digital health in heart failure. He has recently taken up a post as Heart Failure Attending at Mount Sinai Hospital in Toronto.
Javier T. Solera, MD
Chief fellow, Transplant Infectious
Diseases, University Health Network
Transplant Infectious Diseases international fellow trained at Hospital 12 de Octubre in Madrid, Spain. He holds a Master's degree in Statistics in Health Sciences from Autonomous University of Barcelona, Spain, and he is a PhD candidate for his project titled "Optimization of the management of COVID-19 in Solid Organ Transplant Recipients". Currently, he is the chief fellow of the Multiorgan Transplant Program at the Ajmera Transplant Centre and was awarded the 2022 Ajmera Transplant Centre Research Fellow Award. Additionally, Dr. Solera is a member of the American Society of Transplantation and has been awarded the 2023 Young Investigator Award.
Jeffrey Schiff, MD FRCP(C)
Associate Professor of Medicine,
University of Toronto
Medical Director, Pancreas and Clinical Islet Transplant Program
Ajmera Transplant Centre and Division of Nephrology, University Health Network
Dr. Jeffrey Schiff is an Associate Professor of Medicine at the University of Toronto. He is the Medical Director of the Pancreas and Clinical Islet Transplant Program in the Ajmera Transplant Centre, University Health Network. Currently, he is the President of the Canadian Society of Transplantation. He is active in solid organ transplantation and nephrology education at the local and national levels, including as a Program and Fellowship Director, activities the Royal College of Physicians and Surgeons of Canada, the CST and web-based initiatives. His clinical focus is in kidney and kidney-pancreas transplantation.
Juan Duero, MD, MSc, FRCPC
Assistant Professor - University
of Toronto
Cardiology, Advanced
HF - Peter Munk Cardiac Centre
Cardiac Transplantation - Ajmera
Transplant Centre
Dr. Duero Posada is an advanced heart failure and transplant cardiologist at the University Health Network. His Clinical appointment is as a Clinician in Quality Improvement and Innovation. He is the Program Director for the advanced heart failure and transplant fellowship. His main areas of interest are quality indicators in transplantation, standardization of care, and the use of technology in facilitating transitions of care.
Julie Tan, MD PhD FRCPC
Gastroenterology resident, McMaster
University
Dr. Julie Tan obtained her PhD in Molecular Genetics at SickKids Hospital and the University of Toronto. She then went on to complete medical school at the University of Toronto, and Internal Medicine residency at McMaster University, where she is also completing her Gastroenterology fellowship. She will soon be joining the Toronto Centre for Liver Disease as a Clinical Fellow in Hepatology at the University of Toronto.
Matthew Binnie, MD
Staff Respirologist, Toronto Lung Transplant Program, Ajmera Transplant Centre
My clinical interests are in lung transplantation and interstitial lung diseases./p>
Michael McDonald, MD, FRCPC
Associate Professor, Division of
Cardiology, University of Toronto
Medical
Director, Heart Transplant Program, UHN/Ajmera Transplant Centre
Dr. McDonald is currently an Associate Professor in the Division of Cardiology at the University Health Network/Mount Sinai Hospital, where his clinical focus is the management of patients with advanced heart failure, cardiac transplantation and implantable device therapy. He is the Medical Director of the Adult Heart Transplant Program at the Ajmera Transplant Centre and the inaugural Martha Rogers Chair in Heart Failure Training and Education. He is the past president of the Canadian Cardiac Transplant Network and the past chair of the Canadian Cardiovascular Society’s Heart Failure Guidelines Committee.
Nazia Selzner, MD, PhD
Associate Professor of Medicine,
University of Toronto
Medical
Director, Live Donor Liver Transplantation, Ajmera Transplant Centre
Dr. Nazia Selzner is a Transplant Hepatologist and Medical Director of the Living Donor Liver Transplantation at the Ajmera Transplant Center, University Health Network, and Associate Professor of Medicine at the University of Toronto. Dr. Nazia Selzner is a Scientist at the Institute for Medical Science (IMS) as well as at the Toronto General Research Institute (TGRI). Dr. Selzner graduated from Medical School at the University of Paris VII, France and completed her Gastroenterology training in France. She completed her PhD in 2003 at the University of Paris VII, France, after four years of research fellowship at Duke University Medical Center, Durham, NC and at the University of Zurich, Switzerland. Her research interest is in on mechanism of ischemia/reperfusion injury of the liver. Her clinical research is focused on access to liver transplantation and living donor liver transplantation. She is recipient of numerous national and international awards and has published extensively in the area of living organ donation, transplantation outcome and reperfusion injury. She is President-Elect of International Liver Transplantation Society (ILTS) and Executive Editor of Transplantation International.
Sunita Singh, MD, MSc, FRCPC
Assistant Professor of Medicine,
University of Toronto
Medical Director, Living Kidney Donation Program, Ajmera Transplant Centre
Dr. Sunita Singh is a transplant nephrologist in the Division of Nephrology and the medical director of the living kidney donation program at the Toronto General Hospital, University Health Network. She is also an Assistant Professor of Medicine at the University of Toronto. Dr. Singh completed medical school at the University of Toronto, and internal medicine and chief medical residency at the University of British Columbia. She returned to Toronto to complete a Master of Science in clinical epidemiology and health care research, as well as additional fellowship training in kidney transplantation and advanced diabetes care. Dr. Singh’s research interests are focused on the evaluation and follow-up of living kidney donors, as well as the management of diabetes in kidney transplant recipients.
Trevor Reichman, MD, PhD,
Associate Professor, Department
of Surgery, University of Toronto
Surgical Director, Pancreas and Islet Cell Transplantation, Ajmera
Transplant Centre, University Health Network
Dr. Reichman completed his residency in General Surgery at the University of Chicago Medical Center and subsequently performed a fellowship in Abdominal Organ Transplantation and HPB Surgery in Toronto. Following his fellowship, Dr. Reichman moved to the Ochsner Medical Center in New Orleans, Louisiana where he assumed the role of Co-Director of Living Donor Liver Transplantation and Pediatric Liver Transplantation. He also started and was the Director of the abdominal transplant fellowship at Ochsner. After 5 years, he relocated to Virginia Commonwealth University in Richmond, Virginia where he was the Surgical Director of Liver Transplantation and the Director of Pediatric Liver Transplantation. In 2019, he returned to the Division of General Surgery and the UHN Transplant Program at Toronto General Hospital and has joined as a member of the Abdominal Organ Transplant and HPB Surgery team. He has assumed the role of Surgical Director of the Pancreas Transplant Program and is directing the surgical fellowships for abdominal transplantation and HPB surgery at the University of Toronto. His research interests include organ preservation with a specific interest in normothermic perfusion and islet cell transplantation.
SPEAKERS - May 26th
Sarah Crome,PhD,
Assistant Professor | University of Toronto | Faculty of Medicine | Department of Immunology Scientist | University Health Network | Toronto General Hospital Research Institute | Multi Organ Transplant Medicine by Design Investigator
Dr. Sarah Crome was recruited to the University of Toronto and a Scientist at the Toronto General Hospital Research Institute within the University Health Network (UHN) in September 2018. Her expertise is in human immunology, immune tolerance and immunotherapy. Dr. Crome’s research is focused on uncovering cells and molecules that regulate immune tolerance, and identifying underlying causes of transplant rejection. Her translational research as part of the Multi Organ Transplant Program at UHN involves the identification of novel immunotherapeutic targets and development of cell-based therapies for transplantation and autoimmunity.
Dr Crome’s scientific career started at the University of British Columbia with Dr. Megan Levings, where her research defined molecular, epigenetic and cellular regulatory mechanism that control human CD4+ T helper 17 cell development and their pro-inflammatory functions. Her postdoctoral work with Dr. Pamela Ohashi at Princess Margaret Cancer Centre discovered a novel innate lymphoid cell (ILC) population that inhibits the activity and expansion of tumour-associated T cells and is associated with poorer clinical outcomes in ovarian cancer. Dr. Crome holds the Next Generation of Scientists award from the Cancer Research Society and is a Medicine By Design Investigator.
Fadi Issa
Fadi Issa DPhil FRCS, Associate Professor and Consultant Burns and Plastic Surgeon, leads the Transplantation Research Immunology Group (TRIG), Oxford. Programmes of work at TRIG comprise basic science investigation of regulatory T cell biology, advanced biomarker studies of transplant recipients, and clinical cellular therapeutics. The latter includes the ONE Study consortium of regulatory cellular therapies, and the randomised controlled phase IIb TWO Study of autologous polyclonal Tregs in living donor renal transplantation. Other work includes the use of tissue spatial technologies for deep profiling of tissues in transplantation, infection, and cancer. He is Deputy Editor of Transplantation, a Steering Committee member of the Federation of Clinical Immunology Societies, and Chair of the Transplantation Society’s Basic and Translational Science Committee.
Event Date:
May 25, 2023 (virtual only)
- Virtual (Zoom)
May 26, 2023 (in person only)
- Victoria University in the University of Toronto, 91 Charles St W (Vic Building)
Information & Assistance:
Conference Services
conferences@uhn.ca.
We do not issue letters of invitation to international delegates. Administrative fees will apply to cancelled registrations.
Copyright© 2017 | MYConference Suite Registration | D.E. Systems | All Right Reserved.